Hanmi Science Co Ltd
KRX:008930
Hanmi Science Co Ltd
KRX:008930
Price:
38 450
KRW
2.26%
Market Closed
Market Cap:
₩2.6T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hanmi Science Co Ltd
KRX:008930
|
KR |
|
F
|
Fineqia International Inc
CNSX:FNQ
|
CA |
|
Acrux Ltd
ASX:ACR
|
AU |
|
S.A.M Trade (Asia) Pte Ltd
OTC:SMFX
|
US |
|
C
|
Cipta Selera Murni Tbk PT
IDX:CSMI
|
ID |
|
AFC Group Holdings Ltd
NZX:AFC
|
NZ |
|
ABC India Ltd
BSE:520123
|
IN |
|
Guilin Layn Natural Ingredients Corp
SZSE:002166
|
CN |
|
P
|
Pecca Group Bhd
KLSE:PECCA
|
MY |
|
C&D Property Management Group Co Ltd
HKEX:2156
|
CN |
|
Pelayaran Tamarin Samudra Tbk PT
IDX:TAMU
|
ID |
|
freenet AG
XETRA:FNTN
|
DE |
|
ASML Holding NV
AEX:ASML
|
NL |
|
3i Group PLC
LSE:III
|
UK |
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
TW |
|
H
|
Hyperdynamics Corp
OTC:HDYNQ
|
US |
|
Cable One Inc
NYSE:CABO
|
US |
|
Daiwa Securities Group Inc
TSE:8601
|
JP |
|
GS Yuasa Corp
TSE:6674
|
JP |
|
C
|
Cyrela Brazil Realty SA Empreendimentos e Participacoes
OTC:CYRBY
|
BR |
|
Phoenix New Media Ltd
NYSE:FENG
|
CN |
|
Genesis Metals Corp
XTSX:GIS
|
CA |
|
Societe Fonciere Lyonnaise SA
PAR:FLY
|
FR |
|
ABN Amro Bank NV
OTC:AAVMY
|
NL |
Relative Value
The Relative Value of one
Hanmi Science Co Ltd
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 38 450 KRW,
Hanmi Science Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hanmi Science Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Hanmi Science Co Ltd Competitors
Hanmi Science Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Hanmi Science Co Ltd
KRX:008930
|
2.6T KRW | 1.9 | 22 | 40.3 | 47 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.4 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
